Why Did Allurion Stock Surge Over 50% Today?

robot
Abstract generation in progress

Allurion Technologies Inc. (ALUR) stock surged over 50% following the U.S. FDA’s premarket approval for its Gastric Balloon System, featuring the swallowable Allurion Smart Capsule. This non-surgical weight-loss treatment offers an alternative to GLP-1 medications and bariatric surgery for over 100 million Americans affected by obesity. The Smart Capsule remains in the stomach for about four months, helping patients feel fuller and reduce food intake.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin